Tactile Systems Technology, Inc. Research and Development Expense
Tactile Systems Technology, Inc. (TCMD) reported Research and Development Expense of $2.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- Tactile Systems Technology, Inc. research and development expense for the quarter ending 2026-06-30 was $2.50M, a 23.93% increase year-over-year.
- Tactile Systems Technology, Inc. research and development expense for the quarter ending 2026-03-31 was $2.78M, a 59.45% increase year-over-year.
- Tactile Systems Technology, Inc. research and development expense for the quarter ending 2025-12-31 was $2.53M, a 24.19% increase year-over-year.
- Tactile Systems Technology, Inc. research and development expense for the quarter ending 2025-09-30 was $2.19M, a 9.35% decline year-over-year.
- Tactile Systems Technology, Inc. research and development expense for fiscal 2025 was $8.48M, a 3.97% decline from fiscal 2024.
- Tactile Systems Technology, Inc. research and development expense for fiscal 2024 was $8.83M, a 12.90% increase from fiscal 2023.
- Tactile Systems Technology, Inc. research and development expense for fiscal 2023 was $7.82M, a 10.37% increase from fiscal 2022.
- Tactile Systems Technology, Inc. research and development expense for fiscal 2022 was $7.09M, a 25.25% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.50M 10-Q · filed 2026-08-10 | $5.28M 10-Q · filed 2026-08-10 | $7.81M derived: sum of 3 quarters · filed 2026-08-10 | $10.00M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $2.78M 10-Q · filed 2026-05-04 | $5.31M derived: sum of 2 quarters · filed 2026-05-04 | $7.50M derived: sum of 3 quarters · filed 2026-05-04 | $9.52M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $4.72M derived: sum of 2 quarters · filed 2026-02-17 | $6.74M derived: sum of 3 quarters · filed 2026-08-10 | $8.48M 10-K · filed 2026-02-17 |
| 2025-09-30 | $2.19M 10-Q · filed 2025-11-03 | $4.21M derived: sum of 2 quarters · filed 2026-08-10 | $5.95M 10-Q · filed 2025-11-03 | $7.99M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $2.02M 10-Q · filed 2026-08-10 | $3.76M 10-Q · filed 2026-08-10 | $5.80M derived: sum of 3 quarters · filed 2026-08-10 | $8.21M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $1.74M 10-Q · filed 2026-05-04 | $3.78M derived: sum of 2 quarters · filed 2026-05-04 | $6.20M derived: sum of 3 quarters · filed 2026-05-04 | $8.43M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $4.46M derived: sum of 2 quarters · filed 2026-02-17 | $6.69M derived: sum of 3 quarters · filed 2026-02-17 | $8.83M 10-K · filed 2026-02-17 |
| 2024-09-30 | $2.42M 10-Q · filed 2025-11-03 | $4.65M derived: sum of 2 quarters · filed 2025-11-03 | $6.79M 10-Q · filed 2025-11-03 | $8.59M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $2.23M 10-Q · filed 2025-08-04 | $4.38M 10-Q · filed 2025-08-04 | $6.17M derived: sum of 3 quarters · filed 2026-02-17 | $8.13M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $2.14M 10-Q · filed 2025-05-05 | $3.94M derived: sum of 2 quarters · filed 2026-02-17 | $5.90M derived: sum of 3 quarters · filed 2026-02-17 | $7.73M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $3.76M derived: sum of 2 quarters · filed 2026-02-17 | $5.59M derived: sum of 3 quarters · filed 2026-02-17 | $7.82M 10-K · filed 2026-02-17 |
| 2023-09-30 | $1.96M 10-Q · filed 2024-11-04 | $3.80M derived: sum of 2 quarters · filed 2024-11-04 | $6.03M 10-Q · filed 2024-11-04 | $8.17M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $1.83M 10-Q · filed 2024-08-05 | $4.07M 10-Q · filed 2024-08-05 | $6.21M derived: sum of 3 quarters · filed 2025-02-18 | $7.79M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $2.23M 10-Q · filed 2024-05-06 | $4.37M derived: sum of 2 quarters · filed 2025-02-18 | $5.95M derived: sum of 3 quarters · filed 2025-02-18 | $7.80M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $3.72M derived: sum of 2 quarters · filed 2025-02-18 | $5.57M derived: sum of 3 quarters · filed 2025-02-18 | $7.09M 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.58M 10-Q · filed 2023-11-06 | $3.43M derived: sum of 2 quarters · filed 2023-11-06 | $4.95M 10-Q · filed 2023-11-06 | $6.72M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $1.85M 10-Q · filed 2023-08-07 | $3.37M 10-Q · filed 2023-08-07 | $5.14M derived: sum of 3 quarters · filed 2024-02-20 | $6.55M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $1.52M 10-Q · filed 2023-05-08 | $3.29M derived: sum of 2 quarters · filed 2024-02-20 | $4.70M derived: sum of 3 quarters · filed 2024-02-20 | $5.91M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $3.18M derived: sum of 2 quarters · filed 2024-02-20 | $4.39M derived: sum of 3 quarters · filed 2024-02-20 | $5.66M 10-K · filed 2024-02-20 |
| 2021-09-30 | $1.41M 10-Q · filed 2022-11-07 | $2.62M derived: sum of 2 quarters · filed 2022-11-07 | $3.88M 10-Q · filed 2022-11-07 | $5.26M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $1.21M 10-Q · filed 2022-08-01 | $2.48M 10-Q · filed 2022-08-01 | $3.85M derived: sum of 3 quarters · filed 2023-02-21 | $4.95M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $1.27M 10-Q · filed 2022-05-02 | $2.64M derived: sum of 2 quarters · filed 2023-02-21 | $3.75M derived: sum of 3 quarters · filed 2023-02-21 | $4.85M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $2.48M derived: sum of 2 quarters · filed 2023-02-21 | $3.58M derived: sum of 3 quarters · filed 2023-02-21 | $5.26M 10-K · filed 2023-02-21 |
| 2020-09-30 | $1.10M 10-Q · filed 2021-11-08 | $2.21M derived: sum of 2 quarters · filed 2021-11-08 | $3.89M 10-Q · filed 2021-11-08 | $5.08M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $1.10M 10-Q · filed 2021-08-02 | $2.79M 10-Q · filed 2021-08-02 | $3.98M derived: sum of 3 quarters · filed 2022-02-23 | $5.45M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $1.68M 10-Q · filed 2021-05-03 | $2.88M derived: sum of 2 quarters · filed 2022-02-23 | $4.34M derived: sum of 3 quarters · filed 2022-02-23 | $5.58M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $2.66M derived: sum of 2 quarters · filed 2022-02-23 | $3.89M derived: sum of 3 quarters · filed 2022-02-23 | $5.17M 10-K · filed 2022-02-23 |
| 2019-09-30 | $1.47M 10-Q · filed 2020-11-02 | $2.70M derived: sum of 2 quarters · filed 2020-11-02 | $3.98M 10-Q · filed 2020-11-02 | $5.32M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $1.23M 10-Q · filed 2020-08-03 | $2.52M 10-Q · filed 2020-08-03 | $3.85M derived: sum of 3 quarters · filed 2021-02-23 | $5.08M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $1.28M 10-Q · filed 2020-05-04 | $2.62M derived: sum of 2 quarters · filed 2021-02-23 | $3.84M derived: sum of 3 quarters · filed 2021-02-23 | $5.13M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $2.56M derived: sum of 2 quarters · filed 2021-02-23 | $3.85M derived: sum of 3 quarters · filed 2021-02-23 | $5.29M 10-K · filed 2021-02-23 |
| 2018-09-30 | $1.22M 10-Q · filed 2019-11-04 | $2.51M derived: sum of 2 quarters · filed 2019-11-04 | $3.95M 10-Q · filed 2019-11-04 | $5.31M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $1.29M 10-Q · filed 2019-08-05 | $2.73M 10-Q · filed 2019-08-05 | $4.09M derived: sum of 3 quarters · filed 2020-02-26 | $5.20M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $1.44M 10-Q · filed 2019-05-06 | $2.80M derived: sum of 2 quarters · filed 2020-02-26 | $3.91M derived: sum of 3 quarters · filed 2020-02-26 | $5.38M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $2.48M derived: sum of 2 quarters · filed 2020-02-26 | $3.94M derived: sum of 3 quarters · filed 2020-02-26 | $5.06M 10-K · filed 2020-02-26 |
| 2017-09-30 | $1.12M 10-Q · filed 2018-11-05 | $2.58M derived: sum of 2 quarters · filed 2018-11-05 | $3.70M 10-Q · filed 2018-11-05 | $4.86M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $1.47M 10-Q · filed 2018-08-06 | $2.58M 10-Q · filed 2018-08-06 | $3.75M derived: sum of 3 quarters · filed 2019-02-28 | $5.03M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $1.12M 10-Q · filed 2018-05-07 | $2.28M derived: sum of 2 quarters · filed 2019-02-28 | $3.56M derived: sum of 3 quarters · filed 2019-02-28 | $4.61M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.45M derived: sum of 2 quarters · filed 2019-02-28 | $3.50M derived: sum of 3 quarters · filed 2019-02-28 | $4.48M 10-K · filed 2019-02-28 |
| 2016-09-30 | $1.28M 10-Q · filed 2017-11-07 | $2.33M derived: sum of 2 quarters · filed 2017-11-07 | $3.31M 10-Q · filed 2017-11-07 | $4.70M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $1.05M 10-Q · filed 2017-08-07 | $2.03M 10-Q · filed 2017-08-07 | $3.42M derived: sum of 3 quarters · filed 2018-02-26 | $4.51M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $980.00K 10-Q · filed 2017-05-08 | $2.37M derived: sum of 2 quarters · filed 2018-02-26 | $3.46M derived: sum of 3 quarters · filed 2018-02-26 | $4.47M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $2.48M derived: sum of 2 quarters · filed 2018-02-26 | $3.50M derived: sum of 3 quarters · filed 2018-02-26 | $4.31M 10-K · filed 2018-02-26 |
| 2015-09-30 | $1.09M 10-Q · filed 2016-11-10 | $2.10M derived: sum of 2 quarters · filed 2016-11-10 | $2.92M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $1.01M 10-Q · filed 2016-09-07 | $1.83M 10-Q · filed 2016-09-07 | ||
| 2014-12-31 | $2.84M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |